EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Functional characterization of furin-mediated lipoprotein lipase cleavage

Ming Jing Wu, Chelsea Yang, Sirui Wu, Garth Devlin, Feng-Chang Lin, Aravind Asokan, Saskia B Neher iD

Disease Models & Mechanisms · 2026

DOI: 10.1242/dmm.052897 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Disease Models & Mechanisms, 2026. Verfasst von Ming Jing Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Biophysics, The University of North Carolina Chapel Hill, Chapel Hill, North Carolina 27599, USA. Hauptthemen laut MEDLINE: Lipoprotein Lipase, Furin, Proteolysis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NCATS NIH HHS, National Heart Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipoprotein lipase (LPL) is the rate-limiting enzyme that hydrolyzes triglycerides within circulating lipoproteins. LPL dysfunction leads to familial LPL deficiency, which is characterized by chylomicronemia and high risk for acute pancreatitis. Although cell culture studies indicate that the protease furin inactivates LPL by cleavage, the physiological relevance of this process remains unclear. In this study, we investigated the impact of furin-mediated LPL cleavage in vivo using inducible knockout mouse models and gene therapy. After identifying the tissue-specific prevalence of LPL cleavage, we compared mice expressing a furin-resistant LPL mutant versus furin-sensitive LPL. Our results demonstrate that furin-resistant LPL lowers longitudinal plasma triglyceride levels without causing adverse effects, such as hepatic steatosis. These findings highlight that engineered furin resistance is a viable strategy to enhance the metabolic function of LPL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipoprotein LipaseFurinProteolysisAnimalsTriglyceridesMice, KnockoutHyperlipoproteinemia Type IGenetic TherapyMutationLiverFatty LiverHumans

Stichwörter der Autor:innen

Familial lipoprotein lipase deficiencyFurin proteaseGene therapyHypertriglyceridemiaLipoprotein lipase

Substanzen

Lipoprotein LipaseFurinTriglycerides

Autor:innen und Institutionen

  • Department of Biochemistry and Biophysics, The University of North Carolina Chapel Hill, Chapel Hill, North Carolina 27599, USA.
  • Department of Biostatistics, UNC Gillings School of Global Health, Chapel Hill, NC 2759, USA.
  • Department of Surgery, Duke University School of Medicine, Durham, NC 27710, USA.

ORCID-Profile: Saskia B Neher

Förderung

  • NHLBI NIH HHS
  • NCATS NIH HHS
  • National Heart Lung, and Blood Institute
  • NCI NIH HHS
  • North Carolina Translational and Clinical Sciences (NC TraCS) Institute, University of North Carolina at Chapel Hill
  • University of North Carolina at Chapel Hill

Zitieren

APA

Wu, M. J., Yang, C., Wu, S., Devlin, G., Lin, F. C., Asokan, A., & Neher, S. B. (2026). Functional characterization of furin-mediated lipoprotein lipase cleavage. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.052897

Vancouver

Wu MJ, Yang C, Wu S, Devlin G, Lin FC, Asokan A, et al. Functional characterization of furin-mediated lipoprotein lipase cleavage. Disease Models & Mechanisms. 2026. doi:10.1242/dmm.052897

BibTeX
@article{Wu2026,
  author = {Wu, Ming Jing and Yang, Chelsea and Wu, Sirui and Devlin, Garth and Lin, Feng-Chang and Asokan, Aravind and Neher, Saskia B},
  title = {Functional characterization of furin-mediated lipoprotein lipase cleavage},
  journal = {Disease Models & Mechanisms},
  year = {2026},
  doi = {10.1242/dmm.052897}
}
Kostenlos starten →